Lung Cancer: Targeted Therapy in 2025

Lung cancer treatment has changed in the last twenty years since the discovery of EGFR mutations. In this article, we will review the current state of the art for non-small cell lung cancer (NSCLC) actionable genomic alterations (AGA). AGAs are mostly found in lung adenocarcinomas, a subtype of non-...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicole Bouchard, Nathalie Daaboul
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/32/3/146
Tags: Add Tag
No Tags, Be the first to tag this record!